| 000 | 01820 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518091756.0 | ||
| 264 | 0 | _c20210531 | |
| 008 | 202105s 0 0 eng d | ||
| 022 | _a1535-6345 | ||
| 024 | 7 |
_a10.1016/j.currproblcancer.2020.100561 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNakra, Tripti | |
| 245 | 0 | 0 |
_aEpidermal growth factor receptor mutation status in pulmonary adenocarcinoma: Multi-institutional data discussion at national conference of "Lung Cancer Management in Indian context". _h[electronic resource] |
| 260 |
_bCurrent problems in cancer _c06 2020 |
||
| 300 |
_a100561 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma of Lung _xdrug therapy |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aErbB Receptors _xgenetics |
| 650 | 0 | 4 | _aExons |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHigh-Throughput Nucleotide Sequencing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndia |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aMehta, Anurag | |
| 700 | 1 | _aBal, Amanjit | |
| 700 | 1 | _aNambirajan, Aruna | |
| 700 | 1 | _aMishra, Deepak | |
| 700 | 1 | _aMidha, Divya | |
| 700 | 1 | _aGupta, Nalini | |
| 700 | 1 | _aArora, Neeraj | |
| 700 | 1 | _aGupta, Parul | |
| 700 | 1 | _aGupta, Pragya | |
| 700 | 1 | _aSingh, Varsha | |
| 700 | 1 | _aJain, Deepali | |
| 773 | 0 |
_tCurrent problems in cancer _gvol. 44 _gno. 3 _gp. 100561 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.currproblcancer.2020.100561 _zAvailable from publisher's website |
| 999 |
_c30739498 _d30739498 |
||